Literature DB >> 20450417

Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom.

Vhairi Wilson1, Liz Cheek, Giovanni Satta, Karen Walker-Bone, Marc Cubbon, Diane Citron, Dale N Gerding, Martin J Llewelyn.   

Abstract

We assessed the relationship between strain type, clinical factors, and outcome in 128 patients with Clostridium difficile infection. Strain type was not associated with any outcome measure. On multivariate analysis, ischemic heart disease and hypoalbuminemia predicted death. Metronidazole treatment in severe disease was associated with a higher rate of treatment failure and death.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20450417     DOI： 10.1086/653012

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  31 in total

1.  Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.

Authors:  Stéphanie Sirard; Louis Valiquette; Louis-Charles Fortier
Journal:  J Clin Microbiol       Date:  2011-09-28       Impact factor: 5.948

2.  Clostridium difficile colitis acquired in the intensive care unit: outcome and prognostic factors.

Authors:  L Sabau; A Meybeck; J Gois; P Devos; P Patoz; N Boussekey; P-Y Delannoy; A Chiche; H Georges; O Leroy
Journal:  Infection       Date:  2013-06-19       Impact factor: 3.553

3.  NAP1 strain type predicts outcomes from Clostridium difficile infection.

Authors:  Isaac See; Yi Mu; Jessica Cohen; Zintars G Beldavs; Lisa G Winston; Ghinwa Dumyati; Stacy Holzbauer; John Dunn; Monica M Farley; Carol Lyons; Helen Johnston; Erin Phipps; Rebecca Perlmutter; Lydia Anderson; Dale N Gerding; Fernanda C Lessa
Journal:  Clin Infect Dis       Date:  2014-03-05       Impact factor: 9.079

4.  Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study.

Authors:  Natasa Popovic; Milos Korac; Zorica Nesic; Branko Milosevic; Aleksandar Urosevic; Djordje Jevtovic; Nikola Mitrovic; Aleksandar Markovic; Jelena Jordovic; Natasa Katanic; Aleksandra Barac; Ivana Milosevic
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-03       Impact factor: 3.267

Review 5.  Chronic kidney disease and end-stage renal disease are risk factors for poor outcomes of Clostridium difficile infection: a systematic review and meta-analysis.

Authors:  C Thongprayoon; W Cheungpasitporn; P Phatharacharukul; P J Edmonds; Q Kaewpoowat; P Mahaparn; J Bruminhent; S B Erickson
Journal:  Int J Clin Pract       Date:  2015-07-05       Impact factor: 2.503

6.  Clostridium difficile ribotype does not predict severe infection.

Authors:  Seth T Walk; Dejan Micic; Ruchika Jain; Eugene S Lo; Itishree Trivedi; Eugene W Liu; Luay M Almassalha; Sarah A Ewing; Cathrin Ring; Andrzej T Galecki; Mary A M Rogers; Laraine Washer; Duane W Newton; Preeti N Malani; Vincent B Young; David M Aronoff
Journal:  Clin Infect Dis       Date:  2012-09-12       Impact factor: 9.079

7.  Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.

Authors:  Johanna Sandlund; Amelita Bartolome; Anna Almazan; Stanley Tam; Sheryl Biscocho; Salina Abusali; Jeffrey J Bishop; Niamh Nolan; Joel Estis; John Todd; Stephen Young; Fiona Senchyna; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

8.  Comparison of strain typing results for Clostridium difficile isolates from North America.

Authors:  Fred C Tenover; Thomas Akerlund; Dale N Gerding; Richard V Goering; Therése Boström; Anna-Maria Jonsson; Edith Wong; Alan T Wortman; David H Persing
Journal:  J Clin Microbiol       Date:  2011-03-09       Impact factor: 5.948

9.  Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.

Authors:  Dolors Rodríguez-Pardo; Benito Almirante; Rosa M Bartolomé; Virginia Pomar; Beatriz Mirelis; Ferran Navarro; Alex Soriano; Luisa Sorlí; Joaquín Martínez-Montauti; Maria Teresa Molins; Maily Lung; Jordi Vila; Albert Pahissa
Journal:  J Clin Microbiol       Date:  2013-02-27       Impact factor: 5.948

10.  The role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: a case-control study.

Authors:  J Islam; A L Taylor; K Rao; G Huffnagle; V B Young; C Rajkumar; J Cohen; P Papatheodorou; D M Aronoff; M J Llewelyn
Journal:  Anaerobe       Date:  2014-04-05       Impact factor: 3.331
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.